BradleyWalterLashMD

Oncology • Allentown, PA

Hematologic Oncology

Physician

Join to view full profile

Dr. Lash is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Lash's full profile

Already have an account?

Office
1240 S Cedar Crest Blvd
Ste 401
Allentown, PA 18103
Phone+1 610-402-7880

Fax+1 610-402-7881
Is this information wrong?

Education & Training

Main Line Health System/Lankenau Medical CenterFellowship, Hematology and Medical Oncology, 2009 - 2012
Robert Packer Hospital/GuthrieResidency, Internal Medicine, 2006 - 2009
SUNY Upstate Medical UniversityClass of 2006

Certifications & Licensure

PA State Medical License 2006 - 2024
NY State Medical License 2012 - 2019
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Clinical Trials

Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Start of enrollment: 2008 Aug 08
Active, not recruiting
Phase 3
Sorafenib Tosylate With or Without Doxorubicin Hydrochloride in Treating Patients With Locally Advanced or Metastatic Liver Cancer Start of enrollment: 2010 Feb 15
Completed
Phase 3
Phase 3 Trial in Squamous Non Small Cell Lung Cancer Subjects Comparing Ipilimumab Versus Placebo in Addition to Paclitaxel and Carboplatin Start of enrollment: 2011 Jan 16
Completed
Phase 3
Cisplatin and Etoposide With or Without Veliparib in Treating Patients With Extensive Stage Small Cell Lung Cancer Start of enrollment: 2012 Sep 28
Completed
Phase 1, Phase 2
S1403, Afatinib Dimaleate With or Without Cetuximab in Treating Patients With Newly Diagnosed Stage IV or Recurrent, EGFR Mutation Positive Non-small Cell Lung Cancer Start of enrollment: 2015 May 07
Active, not recruiting
Phase 2, Phase 3
Lung-MAP: Taselisib as Therapy in Treating Patients With Stage IV Squamous Cell Lung Cancer and Positive Biomarker Matches Start of enrollment: 2014 Nov 01
Completed
Phase 2
Lung-MAP: Palbociclib as Second-Line Therapy in Treating Cell Cycle Gene Alteration Positive Patients With Recurrent Stage IV Squamous Cell Lung Cancer Start of enrollment: 2014 Sep 01
Completed
Phase 2, Phase 3
Lung-MAP: Nivolumab With or Without Ipilimumab as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and No Matching Biomarkers Start of enrollment: 2015 Dec 29
Active, not recruiting
Phase 3
The Safety of a High-Dose, Rapid Infusion of Iron Sucrose Start of enrollment: 2017 Jan 01
Withdrawn
Phase 2
Surveillance of Patients With Adenocarcinoma of the Gastroesophageal Junction or Esophagus Start of enrollment: 2016 Dec 01
Terminated
Join now to see all

Publications & Presentations

PubMed

15 citations
Multicenter Phase II Clinical Trial of Gemcitabine and Cisplatin as Neoadjuvant Chemotherapy for Patients With High-Grade Upper Tract Urothelial Carcinoma.
Jonathan A Coleman, Wesley Yip, Nathan C Wong, Daniel D Sjoberg, Bernard H Bochner, Guido Dalbagni, S Machele Donat, Harry W Herr, Eugene K Cha, Timothy F Donahue, Eug...> ;Journal of Clinical Oncology. 2023 Mar 10
25 citations
Neoadjuvant Atezolizumab With Gemcitabine and Cisplatin in Patients With Muscle-Invasive Bladder Cancer: A Multicenter, Single-Arm, Phase II Trial.
Samuel A Funt, Michael Lattanzi, Karissa Whiting, Hikmat Al-Ahmadie, Colleen Quinlan, Min Yuen Teo, Chung-Han Lee, David Aggen, Danielle Zimmerman, Deaglan McHugh, Arl...> ;Journal of Clinical Oncology. 2022 Apr 20
2 citations
Evaluation of thrombophilia testing in the inpatient setting: A single institution retrospective review.
Chun Ting Siu, Zachary Wolfe, Martin DelaTorre, Robert Decker, Kathryn Zaffiri, Bradley Lash> ;Plos One. 2021 Sep 20
3 citations
Light chain cast nephropathy caused by plasmablastic lymphoma of the bladder.
Mehrian Jafarizade, Kiran Goli, Vivette D. D'Agati, Essel Dulaimi, Krupa Daniel, Bradley Lash, Sharon Maynard> ;Clinical Nephrology. Case Studies. 2021 Jan 1
14 citations
Thrombotic Thrombocytopenic Purpura Induced by Immune Checkpoint Inhibitiors: A Case Report and Review of the Literature.
Zeeshan Ali, Muhammad Usman Zafar, Zachary Wolfe, Faisal Akbar, Bradley Lash> ;Cureus. 2020 Oct 29
31 citations
Chemotherapy-induced release of circulating-tumor cells into the bloodstream in collective migration units with cancer-associated fibroblasts in metastatic cancer pati...
Nerymar Ortiz-Otero, Jocelyn R. Marshall, Bradley Lash, Michael R. King> ;BMC Cancer. 2020 Sep 11
6 citations
Patient-reported tolerability of veliparib combined with cisplatin and etoposide for treatment of extensive stage small cell lung cancer: Neurotoxicity and adherence d...
Laurie E. McLouth, Fengmin Zhao, Taofeek K. Owonikoko, Josephine Feliciano, Nisha Mohindra, Suzanne E. Dahlberg, James L. Wade, Gordan Srkalovic, Bradley Walter Lash, ...> ;Cancer Medicine. 2020 Aug 28
35 citations
A systematic review and Bayesian network meta‐analysis of risk of intracranial hemorrhage with direct oral anticoagulants
Zachary Wolfe, Safi U. Khan, Fahad Nasir, C. Raghu Subramanian, Bradley Lash> ;Journal of Thrombosis and Haemostasis. 2018 Jul 1
2 citations
Isolated Left Ventricular Metastasis from Renal Cell Carcinoma: Diagnostic and Therapeutic Dilemma.
Amirahwaty Abdullah, Manidhar Lekkala, Zachary Wolfe, Charumathi Raghu, Safi U. Khan, Mrinalini Krishnan, Lydia Winnicka, Bradley Lash> ;Case Reports in Oncology. 2018 Jun 7
114 citations
Randomized Phase II Trial of Cisplatin and Etoposide in Combination With Veliparib or Placebo for Extensive-Stage Small-Cell Lung Cancer: ECOG-ACRIN 2511 Study.
Taofeek K. Owonikoko, Suzanne E. Dahlberg, Gabriel Sica, Lynne I. Wagner, James L. Wade, Gordan Srkalovic, Bradley Walter Lash, Joseph W. Leach, Ticiana Leal, Charu Ag...> ;Journal of Clinical Oncology. 2017 May 30
3 citations
Acquired von Willebrand Syndrome in IgM Monoclonal Gammopathy as the Presentation of Lymphoplasmacytic Lymphoma
Zachary Wolfe, Bradley Lash> ;Case Reports in Hematology. 2017 May 29
4 citations
Microscale assay for screening of inhibitory activity of Lactobacillus.
Bradley W. Lash, Hassan Gourama, Tami Mysliwiec> ;Biotechniques. 2002 Dec 1
Join now to see all

Press Mentions

'Groundbreaking' Therapies for Sickle Cell Disease Expected in Lehigh Valley in 2024December 30th, 2023

Hospital Affiliations

Lehigh Valley Hospital-Cedar CrestAllentown, Pennsylvania

BradleyWalterLashMD

Dr. Lash is on Doximity

Education & Training

Certifications & Licensure

Awards, Honors, & Recognition

Clinical Trials

Publications & Presentations

Press Mentions

Hospital Affiliations

Viewing the full profile is available to verified healthcare professionals only.